|Day's Range||0.35 - 0.37|
|52 Week Range||0.30 - 0.94|
|PE Ratio (TTM)||-27.68|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
Categories: Yahoo FinanceGet free summary analysis Aoxing Pharmaceutical Co., Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Aoxing Pharmaceutical Co., Inc. – Pfizer Inc., Catalyst Pharmaceuticals, Inc., BioDelivery Sciences International, Inc., Impax Laboratories, Inc., Johnson & Johnson, Mylan N.V., Omeros Corporation, Amicus Therapeutics, Inc., ... Read more (Read more...)
FOSTER CITY, CA / ACCESSWIRE / May 15 , 2017 / Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) today announced that for the third quarter of fiscal year 2017, ended March 31, 2017, the Company reported ...
The Shijiazhuang City, China-based company said it had net income of less than 1 cent on a per-share basis. The specialty pharmaceutical company posted revenue of $5.7 million in the period. The company's ...